Medications
US court rules to protect generic drug makers
Manufacturers of generic drugs cannot be sued for adverse side effects caused by products that they did not themselves design, the US Supreme Court ruled on Monday.
Jun 24, 2013
0
0
Page 12 - News tagged with drug manufacturers
Medications
US warns of cyber attacks on medical devices
US authorities on Thursday warned makers of medical devices and hospital networks to step up efforts to guard against potential cyber attacks.
Jun 13, 2013
0
0
Medications
Added benefit of dapagliflozin is not proven
Dapagliflozin (trade name: Forxiga) has been approved in Germany since November 2012 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal ...
Jun 6, 2013
0
0
Oncology & Cancer
Added benefit of ingenol mebutate is not proven
The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act ...
Jun 6, 2013
0
0
Medications
Aflibercept in AMD: No proof of added benefit
It is not proven that patients with wet age-related macular degeneration benefit from the new drug aflibercept, as the drug manufacturer did not present any suitable data for a comparison with the current standard therapy ...
Jun 5, 2013
0
0
Other
Indian drugs group eyes $5 bn Swedish deal
Indian group Sun Pharmaceutical Industries is in talks to buy leading Swedish drugmaker Meda AB in what could result in a $5 billion takeover, the Wall Street Journal reported on Friday.
May 31, 2013
0
0
Medications
Renaissance in new drugs for rare diseases
Once famously described as "orphan diseases, too small to be noticed, too small to be funded" in the Hollywood drama Lorenzo's Oil, rare diseases are getting unprecedented attention today among drug manufacturers, who are ...
May 13, 2013
0
0
Health
Health industry payment details to be publicly available
(HealthDay)—As part of the National Physician Payment Transparency Program and in compliance with a provision in the Affordable Care Act (ACA), the government will make information about financial relationships between ...
May 2, 2013
0
0
Medications
FDA rejects two HIV drugs from Gilead Sciences
Gilead Sciences Inc. says that the Food and Drug Administration rejected two marketing applications for HIV treatments, citing quality control problems at the company's manufacturing facilities.
Apr 29, 2013
0
0
Medical research
Potential diabetes breakthrough: Researchers discover new hormone spurring beta cell production
Researchers at the Harvard Stem Cell Institute (HSCI) have discovered a hormone that holds promise for a dramatically more effective treatment of type 2 diabetes, a metabolic illness afflicting an estimated 26 million Americans. ...
Apr 25, 2013
0
0
